214 related articles for article (PubMed ID: 10208207)
21. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
Ren CL; Pasta DJ; Rasouliyan L; Wagener JS; Konstan MW; Morgan WJ;
J Pediatr; 2008 Dec; 153(6):746-51. PubMed ID: 18760805
[TBL] [Abstract][Full Text] [Related]
22. High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report.
Mackey JE; Anbar RD
BMC Pediatr; 2004 Sep; 4():19. PubMed ID: 15363106
[TBL] [Abstract][Full Text] [Related]
23. Improving evidence-based care in cystic fibrosis through quality improvement.
McPhail GL; Weiland J; Acton JD; Ednick M; Chima A; VanDyke R; Fenchel MC; Amin RS; Seid M
Arch Pediatr Adolesc Med; 2010 Oct; 164(10):957-60. PubMed ID: 20921354
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis.
Konstan MW; Davis PB
Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial.
Vargas MH; Del-Razo-Rodríguez R; López-García A; Lezana-Fernández JL; Chávez J; Furuya MEY; Marín-Santana JC
BMC Pulm Med; 2017 Dec; 17(1):206. PubMed ID: 29246256
[TBL] [Abstract][Full Text] [Related]
27. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis.
Lahiri T; Guillet A; Diehl S; Ferguson M
Pediatr Pulmonol; 2014 Feb; 49(2):148-53. PubMed ID: 23532925
[TBL] [Abstract][Full Text] [Related]
28. Trends in the use of routine therapies in cystic fibrosis: 1995-2005.
Konstan MW; VanDevanter DR; Rasouliyan L; Pasta DJ; Yegin A; Morgan WJ; Wagener JS; ;
Pediatr Pulmonol; 2010 Dec; 45(12):1167-72. PubMed ID: 20717935
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory approaches to cystic fibrosis airways disease.
Balfour-Lynn IM
Curr Opin Pulm Med; 2007 Nov; 13(6):522-8. PubMed ID: 17901759
[TBL] [Abstract][Full Text] [Related]
30. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
[TBL] [Abstract][Full Text] [Related]
31. Physician prescribing patterns of oral corticosteroids for musculoskeletal injuries.
Harmon KG; Hawley C
J Am Board Fam Pract; 2003; 16(3):209-12. PubMed ID: 12755247
[TBL] [Abstract][Full Text] [Related]
32. A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients.
Lucidi V; Tozzi AE; Bella S; Turchetta A
BMC Pediatr; 2006 May; 6():17. PubMed ID: 16719931
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of airway inflammation in cystic fibrosis].
Abély M
Arch Pediatr; 2007 Nov; 14(11):1350-5. PubMed ID: 17702549
[TBL] [Abstract][Full Text] [Related]
34. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
Konstan MW; Butler SM; Schidlow DV; Morgan WJ; Julius JR; Johnson CA
Pediatr Pulmonol; 1999 Oct; 28(4):248-54. PubMed ID: 10497373
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids as an adjuvant treatment to intravenous antibiotics for cystic fibrosis pulmonary exacerbations: a UK Survey.
Hester KL; Powell T; Downey DG; Elborn JS; Jarad NA
J Cyst Fibros; 2007 Jul; 6(4):311-3. PubMed ID: 17291836
[TBL] [Abstract][Full Text] [Related]
36. New and emerging therapies for pulmonary complications of cystic fibrosis.
Tonelli MR; Aitken ML
Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
[TBL] [Abstract][Full Text] [Related]
37. Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
De Boeck K; De Baets F; Malfroot A; Desager K; Mouchet F; Proesmans M
Eur J Pediatr; 2007 Jan; 166(1):23-8. PubMed ID: 16799799
[TBL] [Abstract][Full Text] [Related]
38. Adherence to the 2007 cystic fibrosis pulmonary guidelines: a national survey of CF care centers.
Glauser TA; Nevins PH; Williamson JC; Abdolrasulnia M; Salinas GD; Zhang J; Debonnett L; Riekert KA
Pediatr Pulmonol; 2012 May; 47(5):434-40. PubMed ID: 22495970
[TBL] [Abstract][Full Text] [Related]
39. Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.
Jaffe A; Balfour-Lynn IM
Paediatr Drugs; 2002; 4(6):381-9. PubMed ID: 12038874
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory therapies for cystic fibrosis-related lung disease.
Nichols DP; Konstan MW; Chmiel JF
Clin Rev Allergy Immunol; 2008 Dec; 35(3):135-53. PubMed ID: 18546078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
